Alembic

Some see this as an opportunity for Indian firms like Alembic, Aurobindo who make both the bulk drug and the formulation

The stock hit a new high of Rs 72, up 8% on BSE after its board approved the proposal of buyback of equity shares of the company at price of Rs 80 per share through tender offer.

The stock up 7% to Rs 63.20 on BSE in intra-day trade after the pharmaceutical company announced that its board will consider share buyback proposal on Tuesday, January 23, 2018.

Alembic has managed to revive from a loss of Rs 12 crore in FY12 to a profit of Rs 145 crore in FY17

Alembic's board rejected the request by Unifi Capital to appoint Murali Rajagopalachari as director

Alembic has increased the number of its projects for product development from 40 in 2013-14 to 200 now

The company is debt-free and is positive that it will help it mobilise funds at low costs from external sources to implement its capital expenditure plans